OECD Home › Directorate for Employment, Labour and Social Affairs › Latest Documents
Policy makers are now facing the challenge of providing a short-term response to the crisis without losing sight of the longer-term structural reforms needed to put pension and healthcare systems on a solid footing in light of population ageing. According to Mr. Gurría, we need pension funds to be more transparent and better regulated but we also need structural reforms in the public pension policies and health care systems.
Young people in Japan are finding it increasingly hard to get stable jobs and the Japanese authorities should expand vocational training schemes and increase social security coverage for young non-regular workers in order to help them.
This third report in the OECD series Sickness, Disability and Work looks specifically at the cases of Denmark, Finland, Ireland and the Netherlands, and highlights the roles of institutions and policies.
A guide for constructing and using composite indicators for policy makers, academics, the media and other interested parties. In particular, this handbook is concerned with indicators which compare and rank country performance.
Presentations at joint Eurofound / OECD workshop on Wage developments, minimum wages and wage flexibility, 27th – 28th November 2008, Paris.
This publication presents reviews of the labour market integration of immigrants and their children in four OECD countries (Belgium, France, the Netherlands and Portugal), and provides country-specific recommendations.
The analyses included in the report show that there are big socio-economic differences in mortality, especially for men, and they appear to have become bigger over time.
The current generation of workers can expect lower pension benefits in retirement than the current generation of pensioners. Private, voluntary pension savings will therefore play a greater role in providing for old age. This paper calculates the size of the “pension gap”.
English, , 771kb
This paper (Health Working Paper No. 39) describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals.